Evidence to guide the optimal timing for pre‐chemotherapy blood tests for early breast, colorectal cancer and diffuse large B‐cell lymphoma

BACKGROUND: Re‐designing services and processes to meet growing demands in chemotherapy services is necessary with increasing treatments. There is little evidence guiding the timing and thresholds to be attained of pre‐chemotherapy blood assessments, namely neutrophils. METHODS: A survey was develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Chambers, Pinkie, Wei, Li, Forster, Martin D., Kipps, Emma, Wong, Ian C. K., Jani, Yogini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607255/
https://www.ncbi.nlm.nih.gov/pubmed/34581509
http://dx.doi.org/10.1002/cam4.4316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607255/
https://www.ncbi.nlm.nih.gov/pubmed/34581509
http://dx.doi.org/10.1002/cam4.4316

Ejemplares similares